
### [MONDO:0018120](http://purl.obolibrary.org/obo/MONDO_0018120)
**Label:** disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement

**Subclasses:** [MONDO:0020504](http://purl.obolibrary.org/obo/MONDO_0020504) (genetic recurrent myoglobinuria), [MONDO:0015611](http://purl.obolibrary.org/obo/MONDO_0015611) (neutral lipid storage disease), [MONDO:0014175](http://purl.obolibrary.org/obo/MONDO_0014175) (mitochondrial DNA depletion syndrome 12), [MONDO:0010155](http://purl.obolibrary.org/obo/MONDO_0010155) (Dorfman-Chanarin disease), [MONDO:0009992](http://purl.obolibrary.org/obo/MONDO_0009992) (myoglobinuria, acute recurrent, autosomal recessive), [MONDO:0010791](http://purl.obolibrary.org/obo/MONDO_0010791) (myoglobinuria, recurrent), [MONDO:0010543](http://purl.obolibrary.org/obo/MONDO_0010543) (Barth syndrome), [MONDO:0012545](http://purl.obolibrary.org/obo/MONDO_0012545) (neutral lipid storage myopathy), [MONDO:0011246](http://purl.obolibrary.org/obo/MONDO_0011246) (megaconial type congenital muscular dystrophy), [MONDO:0008922](http://purl.obolibrary.org/obo/MONDO_0008922) (Sengers syndrome), 

**Corr. equiv. classes:** [OMIM:610717](http://purl.obolibrary.org/obo/OMIM_610717), [Orphanet:111](http://www.orpha.net/ORDO/Orphanet_111), [OMIM:602541](http://purl.obolibrary.org/obo/OMIM_602541), [Orphanet:165](http://www.orpha.net/ORDO/Orphanet_165), [OMIM:268200](http://purl.obolibrary.org/obo/OMIM_268200), [Orphanet:280671](http://www.orpha.net/ORDO/Orphanet_280671), [Orphanet:98907](http://www.orpha.net/ORDO/Orphanet_98907), [Orphanet:98908](http://www.orpha.net/ORDO/Orphanet_98908), [OMIM:302060](http://purl.obolibrary.org/obo/OMIM_302060), [Orphanet:99845](http://www.orpha.net/ORDO/Orphanet_99845), [OMIM:550500](http://purl.obolibrary.org/obo/OMIM_550500), [OMIM:615418](http://purl.obolibrary.org/obo/OMIM_615418), [OMIM:212350](http://purl.obolibrary.org/obo/OMIM_212350), [Orphanet:1369](http://www.orpha.net/ORDO/Orphanet_1369), [OMIM:275630](http://purl.obolibrary.org/obo/OMIM_275630), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 34.95%
- Thing 34.94%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 34.94%
- [HP:0001638](http://purl.obolibrary.org/obo/HP_0001638) (Cardiomyopathy) and [HP:0004302](http://purl.obolibrary.org/obo/HP_0004302) (Functional motor problems) 32.94%
- [HP:0001637](http://purl.obolibrary.org/obo/HP_0001637) (Abnormal myocardium morphology) and [HP:0004302](http://purl.obolibrary.org/obo/HP_0004302) (Functional motor problems) 32.94%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 32.89%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 32.68%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 28.54%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 25.85%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 25.14%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) 22.34%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 18.47%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) 16.00%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 15.95%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 15.26%


